Acceptance and Commitment Therapy for Delusions
- Conditions
- SchizophreniaDelusional Disorder
- Interventions
- Behavioral: Acceptance and Commitment Therapy
- Registration Number
- NCT00657631
- Lead Sponsor
- Weill Medical College of Cornell University
- Brief Summary
Symptoms of schizophrenia have historically been treatment resistant despite advances in psychopharmacology. Acceptance and Commitment Therapy (ACT) has been shown through some preliminary research to be effective with psychotic symptoms (Bach \& Hayes, 2002). ACT is considered part of the "third wave of CBT" along with Dialectical Behavior Therapy (DBT; Linehan, 1993) and Mindfulness-based Cognitive Therapy (MBCT; Segal, Williams, \& Teasdale, 2001). The target of change in ACT is acceptance of symptoms as experiences that a person can have without experiencing distress, and while living a life in accordance with one's values.
The current study assessed the effectiveness of ACT (8 sessions) for delusions. Participants received treatment as usual throughout the study. The intervention followed the protocol of ACT described in Hayes, Strosahl and Wilson (1999) in which treatment will consist of building acceptance, willingness, and commitment to change, clarifying values, defusion of thoughts and feelings, as well as defusion of self. These therapeutic aims attempted to be achieved by the practice of various exercises in and out of session as well as the discussion of various metaphors within session. It was hypothesized that participants will exhibit decreased distress due to delusions, decreased delusional conviction and a reduction of overall anxiety levels from participants' baselines.
- Detailed Description
Four patients were recruited from New York Presbyterian Hospital, Weill Medical College, Payne Whitney Clinic (Manhattan Campus), outpatient psychiatric program. Patients were randomly assigned to a length of baseline before beginning the 8-week ACT treatment. There was be a five-week baseline period for all patients after which two patients will be introduced to ACT treatment in weekly increments. All patients received treatment as usual throughout baseline and ACT treatment. During baseline, patients were assessed by an independent rater every week and during ACT treatment, patients were assessed every other week and at a one-month follow-up. Each participant's assessment results were compared over time, so that there will be an established baseline level of functioning which will be compared to his or her level of functioning during treatment, at the end of treatment, and finally at the one-month follow-up. Hypotheses: It was hypothesized that patients' distress, anxiety and tension due to delusional thinking would decrease over time when comparing baseline to treatment, treatment to outcome, and then outcome to follow-up. Additionally, the number of delusional thoughts and the rate of re-hospitalization was hypothesized to decrease over time.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
-
Patients will be considered for inclusion in the study if they meet DSM IV diagnostic criteria for:
- Schizophrenia
- Schizoaffective disorder
- Schizophreniform Disorder
- Delusional Disorder
- Brief Psychotic Disorder
- Psychotic Disorder NOS with current delusions (assessed via chart review)
- Exclusion criteria include a current diagnosis of Mental Retardation
- Organic psychosis
- An inability to participant due to an acute medical condition
- Substance abuse within the past month, a high level of disorganization
- An inability to speak English
- Lack the ability to give informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A Acceptance and Commitment Therapy Acceptance and Commitment Therapy will be administered to all subjects.
- Primary Outcome Measures
Name Time Method This study will illustrate how patients' distress due to delusional thinking decreases over time when comparing baseline to treatment, treatment to outcome, and then outcome to follow-up. 4-6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Weill Cornell Medical College Oupatient Treatment Program of New York Presbyterian Hospital
🇺🇸New York, New York, United States